Bank of America
ONC

Bank of America’s BeOne Medicines Ltd ONC Stock Holding History

Bank of America’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$120M Buy
405,273
+26,441
+7% +$8.56M 0.01% 988
2025
Q4 		$115M Buy
378,832
+33,576
+10% +$11M 0.01% 1014
2025
Q3 		$118M Buy
345,256
+65,763
+24% +$20M 0.01% 1106
2025
Q2 		$67.7M Sell
279,493
-13,294
-5% -$3.26M 0.01% 1458
2025
Q1 		$79.7M Buy
292,787
+87,207
+42% +$20.4M 0.01% 1243
2024
Q4 		$38M Sell
205,580
-6,235
-3% -$1.27M ﹤0.01% 1733
2024
Q3 		$47.6M Sell
211,815
-75,534
-26% -$13.6M ﹤0.01% 1603
2024
Q2 		$41M Sell
287,349
-65,753
-19% -$10.1M ﹤0.01% 1600
2024
Q1 		$55.2M Buy
353,102
+176,710
+100% +$28.5M 0.01% 1411
2023
Q4 		$31.8M Sell
176,392
-3,726
-2% -$674K ﹤0.01% 1713
2023
Q3 		$32.4M Sell
180,118
-110,818
-38% -$21.9M ﹤0.01% 1596
2023
Q2 		$51.9M Sell
290,936
-19,825
-6% -$4.57M 0.01% 1276
2023
Q1 		$67M Sell
310,761
-3,246
-1% -$779K 0.01% 1171
2022
Q4 		$69.1M Buy
314,007
+12,501
+4% +$2.29M 0.01% 1099
2022
Q3 		$40.6M Sell
301,506
-46,785
-13% -$8.03M ﹤0.01% 1407
2022
Q2 		$56.4M Sell
348,291
-66,175
-16% -$10.3M 0.01% 1204
2022
Q1 		$78.2M Buy
414,466
+180,470
+77% +$38.4M 0.01% 1087
2021
Q4 		$63.4M Sell
233,996
-55,971
-19% -$18.9M 0.01% 1255
2021
Q3 		$105M Buy
289,967
+16,237
+6% +$5.31M 0.01% 929
2021
Q2 		$93.9M Buy
273,730
+17,715
+7% +$5.87M 0.01% 989
2021
Q1 		$89.1M Buy
256,015
+49,124
+24% +$16.3M 0.01% 950
2020
Q4 		$53.5M Buy
206,891
+29,680
+17% +$8.17M 0.01% 1136
2020
Q3 		$50.8M Buy
177,211
+31,426
+22% +$7.39M 0.01% 1076
2020
Q2 		$27.5M Sell
145,785
-45,163
-24% -$7.35M ﹤0.01% 1391
2020
Q1 		$23.5M Sell
190,948
-23,329
-11% -$3.65M ﹤0.01% 1392
2019
Q4 		$35.5M Buy
214,277
+44,551
+26% +$7.4M 0.01% 1409
2019
Q3 		$20.8M Sell
169,726
-2,049
-1% -$272K ﹤0.01% 1798
2019
Q2 		$21.3M Sell
171,775
-25,732
-13% -$3.27M ﹤0.01% 1821
2019
Q1 		$26.1M Buy
197,507
+89,201
+82% +$12M ﹤0.01% 1592
2018
Q4 		$15.2M Sell
108,306
-13,333
-11% -$1.77M ﹤0.01% 1918
2018
Q3 		$20.9M Buy
121,639
+41,168
+51% +$6.92M ﹤0.01% 1783
2018
Q2 		$12.4M Sell
80,471
-99,132
-55% -$17.7M ﹤0.01% 2249
2018
Q1 		$30.2M Buy
179,603
+17,975
+11% +$2.43M 0.01% 1442
2017
Q4 		$15.8M Buy
161,628
+11,319
+8% +$1.04M ﹤0.01% 2014
2017
Q3 		$15.6M Buy
150,309
+128,575
+592% +$9.58M ﹤0.01% 2088
2017
Q2 		$978K Buy
21,734
+1,535
+8% +$60.5K ﹤0.01% 4451
2017
Q1 		$740K Buy
20,199
+1,116
+6% +$40.7K ﹤0.01% 4631
2016
Q4 		$580K Buy
19,083
+417
+2% +$13.1K ﹤0.01% 4716
2016
Q3 		$575K Sell
18,666
-3,220
-15% -$93.5K ﹤0.01% 4526
2016
Q2 		$652K Buy
21,886
+19,293
+744% +$566K ﹤0.01% 4478
2016
Q1 		$76K Buy
+2,593
New +$73.5K ﹤0.01% 5608

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America's ONC Position: Q1 2026 in Review

Bank of America increased its BeOne Medicines Ltd (ONC) stake by 7% in Q1 2026, buying an estimated $8.56M and bringing the position to 405,273 shares worth $120M. The position accounts for 0.01% of the portfolio, ranked #988.

Bank of America first reported a position in ONC in Q1 2016 and has held it in 41 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Bank of America held 405,273 shares of BeOne Medicines Ltd worth $120M as of Q1 2026.
  • Bank of America bought 26,441 BeOne Medicines Ltd shares in Q1 2026, an estimated $8.56M.
  • BeOne Medicines Ltd made up 0.01% of Bank of America's portfolio in Q1 2026, its #988 holding.
  • Bank of America first reported a position in BeOne Medicines Ltd in Q1 2016 and has held it in 41 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.